JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120
CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
Edwards Lifesciences Corp (EW) (Q3 2026) Earnings Call Highlights: Broad-Based TAVR and TMTT ...
Leerink Partners Maintains Outperform on Edwards Lifesciences, Raises Price Target to $112
RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $115
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120
Bernstein Maintains Market Perform on Edwards Lifesciences, Raises Price Target to $106
Edwards Lifesciences (EW) Trial Data Points To Earlier TAVR Use In Moderate Aortic Stenosis
Loading...